Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002736 (
amyotrophic lateral sclerosis
)
19,048
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Redox control of proteins that form disulfide bonds upon oxidative challenge is an emerging topic in the physiological and pathophysiological regulation of protein function. We have investigated the role of the neuronal calcium sensor protein
visinin-like protein 1
(
VILIP-1
) as a novel redox sensor in a cellular system. We have found oxidative stress to trigger dimerization of
VILIP-1
within a cellular environment and identified thioredoxin reductase as responsible for facilitating the remonomerization of the dimeric protein. Dimerization is modulated by calcium and not dependent on the myristoylation of
VILIP-1
. Furthermore, we show by site-directed mutagenesis that dimerization is exclusively mediated by Cys187. As a functional consequence,
VILIP-1
dimerization modulates the sensitivity of cells to an oxidative challenge. We have investigated whether dimerization of
VILIP-1
occurs in two different animal models of
amyotrophic lateral sclerosis
(
ALS
) and detected soluble
VILIP-1
dimers to be significantly enriched in the spinal cord from phenotypic disease onset onwards. Moreover,
VILIP-1
is part of the
ALS
-specific protein aggregates. We show for the first time that the C-terminus of
VILIP-1
, containing Cys187, might represent a novel redox-sensitive motif and that
VILIP-1
dimerization and aggregation are hallmarks of
ALS
. This suggests that
VILIP-1
dimers play a functional role in integrating the cytosolic calcium concentration and the oxidative status of the cell. Furthermore, a loss of
VILIP-1
function owing to protein aggregation in
ALS
could be relevant in the pathophysiology of the disease.
...
PMID:Dimerization of visinin-like protein 1 is regulated by oxidative stress and calcium and is a pathological hallmark of amyotrophic lateral sclerosis. 2474 16